Progress in the development of DNA vaccines against foot-and-mouth disease

Expert Review of Vaccines

Volumn 11, Issue 4, 2012, Pages 481-493

  Fowler, Veronica L ^a   Barnett, Paul V ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

adjuvant; antibody response; cellular response; foot and mouth disease; immunization; plasmid DNA; protection; target species; vaccines

Indexed keywords

BCG VACCINE; BUPIVACAINE; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 4; LEVAMISOLE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PLASMID DNA;

CELLULAR IMMUNITY; DNA IMMUNIZATION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; ENDOCYTOSIS; FOOT AND MOUTH DISEASE; GENE GUN IMMUNIZATION; HUMORAL IMMUNITY; INNATE IMMUNITY; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROTYPE;

ANIMALS; FOOT-AND-MOUTH DISEASE; SHEEP; SHEEP DISEASES; SWINE; SWINE DISEASES; VACCINES, DNA; VIRAL VACCINES;

EID: 84860563624     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.11.198     Document Type: Review

References (111)

1. Nicolau C, Le Pape A, Soriano P, Fargette F, Juhel MF. In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I. Proc. Natl Acad. Sci. USA 80, 1068-1072 (1983). (Pubitemid 13118087)
2. Benvenisty N, Reshef L. Direct introduction of genes into rats and expression of the genes. Proc. Natl Acad. Sci. USA 83, 9551-9555 (1986). (Pubitemid 17223396)
3. Wolff JA, Malone RW, Williams P et al. Direct gene transfer into mouse muscle cells in vivo. Science 247, 1465-1468 (1990).
4. Tang DC, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152-154 (1992).
5. Robinson HL, Hunt LA, Webster RG. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11, 957-960 (1993). (Pubitemid 23218805)
6. Ulmer JG, Donnelly JJ, Parker SE et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749 (1993). (Pubitemid 23114660)
7. Wang B, Ugen KE, Srikantan V et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 90, 4156-4160 (1993). (Pubitemid 23134185)
8. Youmans GP, Youmans AS. Immunogenic activity if a ribosomal fraction obtained from Mycobacterium tuberculosis. J. Bacteriol. 89, 1291-1298 (1965).
9. Berry LJ, Vennman MR. Cellular Antigens. Nowotny A (Ed.). Springer-Verlag, NY, USA, 3-13 (1972).
10. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl Acad. Sci. USA 90, 11478-11482 (1993). (Pubitemid 24008662)
11. Gurunathan S, Klinman DM, Seder R. DNA vaccines: immunology, application, and optimization. Ann. Rev. Immunol. 18, 927-974 (2000). (Pubitemid 30365401)
12. Cichutek K. DNA vaccines: development, standardization and regulation. Intervirology 43, 331-338 (2000). (Pubitemid 32225705)
13. Yankauckas MA, Morrow JE, Parker SE et al. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing the NP gene. DNA Cell Biol. 12, 771-776 (1993). (Pubitemid 24295352)
14. Wolff JA, Ludtke JJ, Acsadi G, Williams P, Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1, 363-369 (1992).
15. Klinman DM, Currie D, Gursel I, Verthelyi D. Use of CpG oligodeoxynucleotides as immune adjuvants. Immunol. Rev. 199, 201-216 (2004). (Pubitemid 38736773)
16. Somasundaram C, Takamatsu H, Andréoni C et al. Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus. Vet. Immunol. Immunopathol. 70, 277-287 (1999). (Pubitemid 29460878)
17. Lodmell DL, Ray NB, Ewalt LC. Gene gun particle-mediated vaccination with plasmid DNA confers protective immunity against rabies virus infection. Vaccine 16, 115-118 (1998). (Pubitemid 27520986)
18. Torres CA, Iwasaki A, Barber BH, Robinson HL. Differential dependence on target site tissue for gene-gun and intramuscular DNA immunisation. J. Virol. 158, 4529-4532 (1997). (Pubitemid 127483769)
19. Feltquate DM, Heaney S, Webster RG, Robinson HL. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunisation. J.Immunol. 158, 2278-2284 (1997). (Pubitemid 127470012)
20. Elnekave M, Furmanov K, Hovav A-H. Intradermal naked plasmid DNA immunization: mechanisms of action. Expert Rev. Vaccines 10(8), 1169-1181 (2011).
21. Wang B, Ugen KE, Srikantan V et al. Gene inoculation generates immune responses against human immunodeficiency virus type I. Proc. Natl Acad. Sci. USA 90, 4157-4805 (1993).
22. Schirmbeck R, Bohm W, Ando K, Chisari FV, Reimann J. Nucleic acid vaccination primes hepatitis B virus surface antigenspecific cytotoxic T lymphocytes in nonresponder mice. J. Virol. 69, 5929-5934 (1995).
23. Kuhrober A, Wild J, Pudollek HP, Chisari FV, Reimann J. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kband Kd-restricted epitopes. Int. Immunol. 9, 1203-1212 (1997). (Pubitemid 27361764)
24. Polo JM, Lim B, Govindarajan S, Lai MM. Replication of hepatitis delta virus RNA in mice after intramuscular injection of plasmid DNA. J. Virol. 69, 5203-5207 (1995).
25. He J, Hoffman SL, Hayes CG. DNA inoculation with a plasmid vector carrying the hepatitis E virus structural protein geneinduces immune response in mice. Vaccine 15, 357-362 (1997). (Pubitemid 27157691)
26. Ghias H, Cai S, Slanina S, Nesburn AB, Wechsler SL. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge. Antiviral Res. 28, 147-157 (1995).
27. McClements WL, Armstrong ME, Keys RD, Liu MA. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl Acad. Sci. USA 93, 11414-11420 (1996). (Pubitemid 26347135)
28. Fynan EF, Robinson HL, Webster RG. Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA Cell Biol. 12, 785-789 (1993). (Pubitemid 24295354)
29. Montgomery DL, Shiver JW, Leander KR et al. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol. 12, 777-783 (1993). (Pubitemid 24295353)
30. Cardoso AI, Blixenkrone-Moller M, Fayolle J, Liu M, Buckland R, Wild TF. Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity. Virology 225, 293-299 (1996). (Pubitemid 26392250)
31. Fooks AR, Jeevarajah D, Warnes A, Wilkinson GW, Clegg JC. Immunization of mice with plasmid DNA expressing the measles virus nucleoprotein gene. Viral Immunol. 9, 65-71 (1996). (Pubitemid 26238082)
32. Cox GJ, Lamb TJ, Babiuk LA. Bovine herpesvirus-1: immune response in mice and cattle injected with plasmid DNA. J. Virol. 67, 5664-5667 (1993). (Pubitemid 23241406)
33. Romito M, Du Plessis DH, Kleef VM, Van Wyk A, Viljoen GJ. DNA-based immunization of a horse using the VP2 gene of african horse sickness virus. Onderstepoort. J. Vet. Res. 66(2), 139-144 (1999). (Pubitemid 129721901)
34. Schrijver RS, Langedijk JP, Keil GM, Middel WG, Maris-Veldhuis M, van Oirschot JT. Immunization of cattle with BHV-1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV. Vaccine 15, 1908-1916 (1997). (Pubitemid 27504687)
35. Suradhat S, Yoo D, Babiuk LA, Griebel P, Baca-Estrada ME. DNA immunization with a bovine rotavirus VP4 gene induces a Th1-like immune response in mice. Viral Immunol. 10, 117-127 (1997). (Pubitemid 27478668)
36. Harpin S, Talbot B, Mbikay M, Elazhary Y. Immune response to vaccination with DNA encoding the bovine viral diarrhea virus major glycoprotein gp53 (E2). FEMS Microbiol. Lett. 146, 229-234 (1997). (Pubitemid 27057727)
37. Sundaram P, Xiao W, Brandsma JL. Particle-mediated delivery of recombinant expression vectors to rabbit skin induces high-titered polyclonal antisera (and circumvents purification of a protein immunogen). Nucleic Acids Res. 24, 1375-1377 (1996). (Pubitemid 26102691)
38. Triyatni M, Jilbert AR, Qiao M, Miller DS, Burrell CJ. Protective efficacy of DNA vaccines against duck hepatitis B virus infection. J. Virol. 72, 84-94 (1998). (Pubitemid 28048816)
39. Olsen CW, Mc Gregor MW, Dybdahl- Sissoko N et al. Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice. Vaccine 15, 1149-1156 (1997). (Pubitemid 27357201)
40. Ward G, Rieder E, Mason PW. Plasmid DNA encoding replicating foot and mouth disease virus genomes induces antiviral immune response in swine. J. Virol. 71, 7442-7447 (1997). (Pubitemid 27391684)
41. Anderson ED, Mourich DV, Fahrenkrug SC, LaPatra S, Shepherd J, Leong JA. Genetic immunization of rainbow trout (Oncorhynchus mykiss) against infectious hematopoietic necrosis virus. Mol. Mar. Biol. Biotechnol. 5, 114-122 (1996). (Pubitemid 27028032)
42. Martins LP, Lau LL, Asano MS, Ahmed R. DNA vaccination against persistent viral infection. J. Virol. 69, 2574-2582 (1995).
43. Gonzalez Armas C, Morello CS, Cranmer LD, Spector DH. DNA immunization confers protection against murine cytomegalovirus infection. J. Virol. 70, 7921-7928 (1996). (Pubitemid 26339100)
44. Sarzotti M, Dean TA, Remington MP, Ly CD, Furth PA, Robbins DS. Induction of cytotoxic T cell responses in newborn mice by DNA immunization. Vaccine 15, 795-797 (1997). (Pubitemid 27287958)
45. Sakaguchi M, Nakamura H, Sonoda K, Hamada F, Hirai K. Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus. Vaccine 14, 747-752 (1996). (Pubitemid 26228056)
46. Pirzadeh B, Dea S. Immune response in pigs vaccinated with plasmid DNA encoding Orf5 of porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 79, 989-999 (1998). (Pubitemid 28203839)
47. Monteil M, LePotier MF, Guillotin J, Cariolet R, Houdayer C, Eloit M. Genetic immunization of seronegative one-dayold piglets against pseudorabies induces neutralizing antibodies but not protection and is ineffective in piglets from immune dams. Vet. Res. 27, 443-452 (1996). (Pubitemid 126496657)
48. Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199, 132-140 (1994). (Pubitemid 24170432)
49. Martinez X, Brandt C, Saddallah F et al. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life. Proc. Natl Acad. Sci. USA 94, 8726-8731 (1997). (Pubitemid 27335107)
50. Robinson HL, Lu S, Mustafa F et al. Simian immunodeficiency virus DNA vaccine trial in macaques. Ann. N Y Acad. Sci. 772, 209-211 (1995). (Pubitemid 26078780)
51. Haynes JR, McCabe DE, Swain WF, Widera G, Fuller JT. Particle-mediated nucleic acid immunization. J. Biotechnol. 44, 37-42 (1996). (Pubitemid 26059093)
52. Heppell J, Lorenzen N, Lorenzen E, Jensen KE, Wu T, Davis HL. Development of DNA vaccines for fish: vector design, antigen expression and demonstration of efficacy using viral haemorrhagic septicaemia virus as model. Fish Shellfish Immunol. 8, 271-286 (1998). (Pubitemid 128179525)
53. Hammond JM, Janse ES, Morrissy CJ et al. A prime-boost vaccination strategy using naked DNA followed by recombinant porcine adenovirus protects pigs from classical swine fever. Vet. Microbiol. 80, 101-119 (2001). (Pubitemid 32276054)
54. Davidson AH, Traub-Dargatz J, Roeheaver R et al. Immunologic responses to West Nile virus in vaccinated and clinically affected horses. J. Am. Vet. Med. Assoc. 226, 240-245 (2005). (Pubitemid 40123299)
55. Garver KA, LaPatra SE, Kurath G. Efficacy of an infectious hematopoietic necrosis (IHN) virus DNA vaccine in Chinook Oncorhynchus tshawytscha and sockeye O. nerka salmon. Dis. Aquat. Org. 64, 13-22 (2005). (Pubitemid 40641108)
56. Bergman PJ, Camps-Palau M, McKnight J et al. Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine 24, 4582-4585 (2006). (Pubitemid 44218845)
57. Thacker EL, Holtkamp D, Khan A, Brown P, Draghia A. Plasmid-mediated growth hormone-releasing hormone efficacy in reducing disease associated withMycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus infection. J. Anim. Sci. 84, 733-742 (2006). (Pubitemid 44405688)
58. Doel TR. FMD Vaccines. virus Res. 91, 81-99 (2003).
59. Rodriguez LL, Gay CG. Development of vaccines toward the global control and eradication of foot-and-mouth disease. Expert Rev. Vaccines 10(3), 377-387 (2011).
60. Brown F. Progress and perspectiveness in the development of a foot-and-mouth disease vaccine by recombinant DNA technology. Progr. Vet. Microbiol. Immunol. 3, 59-72 (1987).
61. Brown F. New approaches to vaccination against foot-and-mouth disease. Vaccine 10, 1022-1026 (1992).
62. Chinsangaram J, Beard C, Mason PW, Zellner M, Ward G, Grubman MJ. Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J. Virol. 72, 4454-4457 (1998). (Pubitemid 28188756)
63. Beard C, Ward G, Rieder E, Chinsangaram J, Grubman MJ, Mason PW. Development of DNA vaccines for foot and mouth disease evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine. J. Biotechnol. 73, 243-249 (1999). (Pubitemid 29376455)
64. Huang H, Yang Z, Xu Q et al. Recombinant fusion protein and DNA vaccines against foot and mouth disease virus infection in guinea pig and swine. Viral Immunol. 12, 1-8 (1999). (Pubitemid 29231645)
65. Wong HT, Cheng SCS, Chan EWC et al. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. Virology 278, 27-35 (2000). (Pubitemid 32002590)
66. Benvenisti L, Rogel A, Kuznetzova L, Bujanover S, Becker Y, Stram Y. Gene gun mediated DNA vaccination against foot-and-mouth disease virus. Vaccine 19, 3885-3895 (2001). (Pubitemid 32566311)
67. Cedillo-Barron L, Foster-Cuevas M, Belsham G, Lefevre F, Parkhouse M. Induction of a protective response in swine vaccinated with DNA encoding foot-andmouth disease virus empty capsid proteins and the 3D polymerase. J. Gen. Virol. 82, 1713-1724 (2001). (Pubitemid 32611513)
68. Wong HT, Cheng SCS, Sin WY, Chan EWC, Sheng ZT, Xie Y. A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2. Vaccine 20, 2641-2647 (2002). (Pubitemid 34600997)
69. Zhang H-Y, Sun S-H, Gui Y-J et al. Optimising strategy for plasmid DNAs containing multiple-epitopes of foot-andmouth disease virus by cis-expression with IL-2. Vaccine 26, 769-777 (2008).
70. Shao HJ, Chen L, Su YB. DNA fragment encoding human IL-1β 163-171 peptide enhances the immune responses elicited in mice by DNA vaccine against foot-andmouth disease. Vet. Res. Comm. 29, 35-46 (2005). (Pubitemid 39480647)
71. Su B, Wang J, Wang X et al. The effects of IL-6 and TNF-a as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination. Vaccine 26, 5111-5122 (2008).
72. Wang X, Zhang X, Kang Y et al. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus. Vaccine 26, 5135-5144 (2008).
73. Zou Q, Wu B, He X et al. Increasing a robust antigen-specific cytotoxic T lymphocyte response by FMDV DNA vaccination with IL-9 expressing construct. J. Biomed. Biotechnol. 2010, 1-8 (2010).
74. Mingxiao M, Ningyi J, Juan LH et al. Immunogenecity of plasmid encoding P12A and 3C of FMDV and swine IL-18. Antivir. Res. 76, 59-67 (2007). (Pubitemid 47176694)
75. Xiao C, Jin H, Hu Y et al. Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants. Antivir. Res. 76, 11-20 (2007). (Pubitemid 47176689)
76. Cedillo-Barron L, Foster-Cuevas M, Cook A et al. Immunogenecity of plasmids encoding T and B cell epitopes of foot-andmouth disease virus (FMDV) in swine. Vaccine 21, 4261-4269 (2003). (Pubitemid 37138696)
77. Shieh JJ, Liang C-M, Chen C-Y et al. Enhancement of the immunity to foot-andmouth disease virus by DNA priming and protein boosting immunization. Vaccine 19, 4002-4010 (2001). (Pubitemid 32566325)
78. Jin H, Kang Y, Xiao C et al. DNA prime followed by protein boost enhances neutralisation and Th1 type immunity against FMDV. Viral Immunol. 18, 539-548 (2005).
79. Zhang HY, Sun SH, Guo YJ et al. Immune response in mice inoculated with plasmid DNAs containing multiple epitopes of foot and mouth disease virus. Vaccine 21, 4704-4707 (2003).
80. Borrego B, Fernandez-Pacheco P, Ganges L et al. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses. Vaccine 24, 3889-3899 (2006).
81. Guo H, Liu Z, Sun S et al. Immune response of guinea pigs vaccinated with DNA vaccine of foot and mouth disease virus O/China99. Vaccine 23, 3236-3242 (2005). (Pubitemid 40523115)
82. +, CTL epitope for Balb/c mice. Antivir. Res. 72, 178-189 (2006). (Pubitemid 44794330)
83. Jin H, Li Y, Ma Z, Zhang F, Xie Q, Gu D, Wang B. Effect of chemical adjuvants on DNA vaccination. Vaccine 22, 2925-2935 (2004). (Pubitemid 38900672)
84. Zhang S, Guo Y-J, Sun S-H et al. DNA vaccination using bacillus Calmette- Geurin DNA as an adjuvant to enhance the immune response to three kinds of swine diseases. Scand. J. Immunol. 62, 371-377 (2005). (Pubitemid 41565389)
85. Chen L, Lin T, Zhang H-X, Su Y-B. Immune response to foot and mouth disease DNA vaccines can be enhanced by co injection with the Isatis indigotica extract. Intervirology 48, 207-212 (2005). (Pubitemid 40827668)
86. Fan H, Tong T, Chen H. Immunisation of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus. Virus Genes 35, 347-357 (2007). (Pubitemid 47087559)
87. Xu H, Zhao G, Huang X et al. CD40-expressing plasmid induces anti-CD40 antibody and enhances immune responses to DNA vaccination. J. Gene Med. 12, 97-106 (2010).
88. Kim S-A, Liang C-M, Cheng I-C et al. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1antigenicity. J. Gene Med. 8, 1182-1191 (2006). (Pubitemid 44480409)
89. Niborski V, Li Y, Brennan F et al. Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV. Vaccine 24, 7204-7213 (2006). (Pubitemid 46127449)
90. Li Y, Aggarwal N, Takamatsu H-H, Stirling C, Voyce C, Barnett PV. Enhancing immune responses against a plasmid DNA vaccine encoding a FMDV empty capids from serotype O. Vaccine 24, 4602-4606 (2006). (Pubitemid 43776757)
91. Li Y-G, Tian F-L, Gao F-S, Tang X-S, Xia C. Immune responses generated by Lactobacillus as a carried in DNA immunisation against foot-and-mouth disease virus. Vaccine 25, 902-911 (2007). (Pubitemid 44856122)
92. Dory D, Remond M, Beven V et al. Pseudorabies virus glycoprotein B can be used to carry foot and mouth disease antigens in DNA vaccination of pigs. Antivir. Res. 81, 217-225 (2009).
93. Wang KY, Guo YJ, Zhang YL, Lv K, Sun SH. Combined DNA vaccination against three animal viruses elicits decreased immunogenicity of a single plasmid in mice. Vaccine 25, 4429-4436 (2007). (Pubitemid 46678566)
94. Yang B, Lan X, Li X et al. A novel bifunctional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induced both rapid inhibitory effect and specific immune responses in mice. Vaccine 26, 5477-5483 (2008).
95. Li Y, Stirling C, Denyer M et al. Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost. Vaccine 26, 2647-2656 (2008).
96. Borrego B, Argilaguet JM, Perez-Marin E et al. A DNA vaccine encoding foot-andmouth disease virus B amd T-cell epitopes targeted to class II swine leukocyte antigens protects pigs against viral challenge. Antivir. Res. 92, 359-363 (2011).
97. Ganges L, Borrego B, Fernandez-Pacheco P et al. DNA immunisation of pigs with footand- mouth disease virus minigenes: from partial protection to disease exacerbation. Vaccine 15, 121-125 (2011).
98. Lu S. Heterologous prime-boost vaccination. Curr. Opin. Immunol. 21, 346-351 (2009).
99. Kent SJ, Zhao A, Best SJ, Chandler JD, Boyle DB, Ramshaw IA. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J. Virol. 72, 10180-10188 (1998). (Pubitemid 28520889)
100. Amara RR, Villinger F, Altman JD et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292, 69-74 (2001). (Pubitemid 32289126)
101. Schneider J, Langermans JA, Gilbert SC et al. A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees. Vaccine 19, 4595-4602 (2001). (Pubitemid 32800740)
102. Rogers WO, Baird JK, Kumar A et al. Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques. Infect. Immun. 69, 5565-5572 (2001). (Pubitemid 32786492)
103. Pancholi P, Lee DH, Liu Q et al. DNA prime/canarypox boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee. Hepatology 33, 448-454 (2001). (Pubitemid 32119035)
104. + T cell responses. J. Immunol. 169, 4778-4787 (2002). (Pubitemid 35217140)
105. Doria-Rose NA, Pierce CC, Hensel MT et al. Multigene DNA prime-boost vaccines for SHIV89.6P. J. Med. Primatol. 32, 218-228 (2003). (Pubitemid 37021247)
106. Shiver JW, Fu TM, Chen L et al. Replication-incompetent adenoviral vaccine vector elicits effective antiimmunodeficiency- virus immunity. Nature 415, 331-335 (2002). (Pubitemid 34087555)
107. Vinner L, Wee EG, Patel S et al. Immunogenicity in Mamu-A.*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost. J. Gen. Virol. 84, 203-213 (2003). (Pubitemid 36113566)
108. Skinner MA, Buddle BM, Wedlock DN et al. A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis. Infect. Immunol. 71, 4901-4907 (2003). (Pubitemid 37070731)
109. Toussaint JF, Letellier C, Paquet D, Dispas M, Kerkhofs P. Prime-boost strategies combining DNA and inactivated vaccines confer high immunity and protection in cattle against bovine herpesvirus-1. Vaccine 23, 5073-5081 (2005). (Pubitemid 41318155)
110. Cheevers WP, Snekvik KR, Trujillo JD, Kumpula-McWhirter NM, Pretty On Top KJ, Knowles DP. Prime-boost vaccination with plasmid DNA encoding caprinearthritis encephalitis lentivirus env and viral SU suppresses challenge virus and development of arthritis. Virology 306, 116-125 (2003). (Pubitemid 36293402)
111. Lopez AM, Hines MT, Palmer GH, Knowles DP, Alperin DC, Hines SA. Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi. Vaccine 21, 3815-3825 (2003). (Pubitemid 37338209)